Faculty Profiles - KATO, Taichi

Papers - KATO, Taichi

Division display 41 - 60 of about 61 ／ All the affair displays >>

Identification of potential pathogenic viruses in patients with acute myocarditis using next-generation sequencing Reviewed

Takeuchi Suguru, Kawada Jun-ichi, Okuno Yusuke, Horiba Kazuhiro, Suzuki Takako, Torii Yuka, Yasuda Kazushi, Numaguchi Atsushi, Kato Taichi, Takahashi Yoshiyuki, Ito Yoshinori

JOURNAL OF MEDICAL VIROLOGY Vol. 90 ( 12 ) page： 1814 - 1821 2018.12

小児循環器疾患の基礎研究から臨床への応用家族性大動脈弁上狭窄において、遺伝子内微小欠失の頻度は高い次世代シーケンサーによる7家系の解析と臨床応用への可能性 Reviewed

早野聡, 奥野友介, 堤真紀子, 稲垣秀人, 深澤佳絵, 倉橋浩樹, 小島勢二, 高橋義行, 加藤太一

日本小児循環器学会雑誌 Vol. 34 ( Suppl.1 ) page： s1 - 122 2018.7

Infliximab versus intravenous immunoglobulin for refractory Kawasaki disease: A phase 3, randomized, open-label, active-controlled, parallel-group, multicenter trial Reviewed International journal

Masaaki Mori, Takuma Hara, Masako Kikuchi, Hiroyuki Shimizu, Tomoyuki Miyamoto, Satoru Iwashima, Tatsuya Oonishi, Kunio Hashimoto, Norimoto Kobayashi, Kenji Waki, Yasuo Suzuki, Yoshikazu Otsubo, Hiroshi Yamada, Chikao Ishikawa, Taichi Kato, Shigeto Fuse

Scientific Reports Vol. 8 ( 1 ) page： 1994 2018.1

Language：English Publishing type：Research paper (scientific journal) Publisher：Nature Publishing Group

We compared the efficacy and safety of infliximab with intravenous immunoglobulin (IVIG), a standard therapy, in a phase 3 trial (NCT01596335) for Japanese patients with Kawasaki disease (KD) showing persistent fever after initial IVIG. Patients with initial IVIG-refractory KD, aged 1-10 years, received a single dose of IV infliximab 5 mg/kg or IV polyethylene glycol-treated human immunoglobulin (VGIH) 2 g/kg on day 0. Primary outcome was defervescence rate within 48 h after the start of treatment. Safety was evaluated through day 56. Overall, 31 patients were randomized (infliximab, n = 16
VGIH, n = 15)
31.3% and 60.0% patients discontinued due to worsening KD. Defervescence rate within 48 h was greater with infliximab (76.7%) than VGIH (37.0%) (p = 0.023), and defervescence was achieved earlier with infliximab (p = 0.0072). Coronary artery lesions occurred in 1 (6.3%) and 3 (20.0%) patients receiving infliximab and VGIH, respectively, up to day 21. Adverse events occurred in 15 (93.8%) and 15 (100.0%) patients in the infliximab and VGIH groups, respectively. No serious adverse events in the infliximab group and one in the VGIH group were observed. Infliximab improved the defervescence rate within 48 h and time to defervescence versus standard therapy, and was well tolerated in patients with IVIG-refractory KD.

DOI： 10.1038/s41598-017-18387-7

Scopus

PubMed

Successful Infant Pneumonectomy with Unilateral Pulmonary Artery Occlusion Test.

Koji Kato, Taichi Kato, Satoshi Hayano, Yoshie Fukasawa, Atsushi Numaguchi, Tetsuo Hattori, Akiko Saito, Yoshiaki Sato, Masahiro Hayakawa

International heart journal Vol. 59 ( 1 ) page： 237 - 239 2018.1

Language：English Publisher：International Heart Journal Association

The use of unilateral pulmonary artery occlusion (UPAO) test for the preoperative evaluation of pneumonectomy was reported in adult patients. On the contrary, in infants, no strategies have yet been recommended to predict hemodynamics after pneumonectomy, nor has use of the UPAO test been reported. We describe the first case of infant with abnormal pulmonary circulation in whom successful pneumonectomy was performed after preoperative evaluation using UPAO test. Right pneumonectomy was planned for an 8-month-old girl, because of decreased right pulmonary function, high risk of pneumothorax, and impaired left lung expansion due to overexpansion caused by severe left bronchial stenosis and bronchomalacia. However, she had also prolonged pulmonary hypertension and there was difficulty in accurate echocardiographic evaluation of its severity due to concomitant left pulmonary artery stenosis. Furthermore, contrast-enhanced computer tomography suggested a certain degree of right pulmonary venous flow, discordant with the result showing scarce right pulmonary flow in perfusion scintigraphy. Predicting postoperative hemodynamic changes was therefore considered difficult. To evaluate these concerns, we performed cardiac catheterization and UPAO test to simulate postoperative hemodynamics. Pulmonary arteriography showed decreased but significant right pulmonary arterial and venous flows. Measurements including pulmonary artery pressure and cardiac index showed no marked changes after occlusion. Based on UPAO test results, the operation was successfully performed and hemodynamics remained stable postoperatively. The UPAO test may be useful for infants with cardiopulmonary impairment to evaluate the tolerability of pneumonectomy.

DOI： 10.1536/ihj.16-606

Scopus

PubMed

CiNii Research

先天性心疾患の手術非介入で経過している 18 トリソミーの検討 Reviewed

今井祐喜，加藤太一，加藤有一，久保田哲夫，服部哲夫

日小児循環器会誌 Vol. 33 ( 4 ) page： 312-317 2017

Screening of Pulmonary Arteriovenous Malformations and Genetic Test in Patients with Hereditary Hemorrhagic Telangiectasia

Kato Taichi

Pediatric Cardiology and Cardiac Surgery Vol. 33 ( 3 ) page： 247 - 248 2017

The Clinical Course of Patients with Trisomy 18 Who Have Not Undergone Cardiac Surgery

Imai Yuki, Kato Taichi, Kato Yuichi, Kubota Tetsuo, Hattori Tetsuo

Pediatric Cardiology and Cardiac Surgery Vol. 33 ( 4 ) page： 312 - 317 2017

Language：Japanese Publisher：Japanese Society of Pediatric Cardiology and Cardiac Surgery

Background: The number of patients with trisomy 18 undergoing cardiac surgery has recently been increasing. In our institute, the primary purpose of treatment in patients with trisomy 18 is to facilitate discharge and cardiac surgery has not yet been performed in such cases. In the present report, we reviewed patients treated at our institute to demonstrate the prognosis of patients with trisomy 18 without cardiac surgery.Methods: We collected detailed clinical information from the medical records of 17 patients with trisomy 18 from April 2005 to December 2015. We retrospectively studied the neonatal condition, survival rate, and cause of death. We also reviewed patients with a high pulmonary flow, the large left-to-right shunt (LS) group, who were at a potential risk of heart failure.Results: All patients had congenital heart disease (CHD). The 1-year survival rate was 64.7%, with 70.6% of patients discharged at a median age of 129 days (range, 16–285 days). The median survival time of patients who died during the present study was 104.5 days (range, 0–1,054 days). In the LS group, 62.5% of patients survived for one year with no evidence of heart failure. Two patients in the LS group died in hospital from heart failure.Conclusions: Favorable survival was achieved through standard neonatal intensive treatment without cardiac surgery. Patients with trisomy 18 complicated by CHD with a high pulmonary flow should be maintained in a stable condition without cardiac surgery due to persistent pulmonary hypertension resulting from vascular abnormalities. Further studies are required to evaluate the long-term effectiveness of cardiac surgery for patients with trisomy 18.

DOI： 10.9794/jspccs.33.312

CiNii Research

Primary psoas abscess caused by group A streptococcus in a child: Case report with microbiologic findings. Reviewed

Kamiya Y, Hasegawa T, Takegami Y, Horiba K1, Ando S, Torii Y, Kidokoro H, Kato T, Natsume J, Kawada JI, Ito Y.

J Infect Chemother Vol. 22 ( 12 ) page： 811-814 2016.12

Abnormal urinalysis on day 7 in patients with IgA vasculitis (Henoch-Schonlein purpura) Reviewed

Kawashima N, Kawada J, Nishikado Y, Kitase Y, Ito S, Muramatsu H, Sato Y, Kato T, Natsume J, Kojima S.

Nagoya J Med Sci Vol. 78 ( 4 ) page： 359-368 2016.11

Feasibility and safety of transseptal puncture procedures for radiofrequency catheter ablation in small children weighing below 30 kg: single-center experience Reviewed

Yoshida S, Suzuki T, Yoshida Y, Watanabe S, Nakamura K, Sasaki T, Kawasaki Y, Ehara E, Murakami Y, Kato T, Nakamura Y.

Europace Vol. 2016 ( 18 ) page： 1581-1586 2016.10

病理組織診断でリウマチ熱による伝導路障害が死因であると疑われた1例 Reviewed

池田麻衣子，小沢広明，永田佳敬，馬場礼三，加藤太一，長井典子.

日小児循環器会誌 Vol. 2016 ( 32 ) page： 423-428 2016.6

Abnormal urinalysis on day 7 in patients with IgA vasculitis (Henoch-Schonlein purpura) Reviewed

Kawashima N, Kawada J, Nishikado Y, Kitase Y, Ito S, Muramatsu H, Sato Y, Kato T, Natsume J, Kojima S.

Nagoya J Med Sci Vol. 2016 ( 78 ) page： 359-367 2016

Macitentan reverses early obstructive pulmonary vasculopathy in rats: Early intervention in overcoming the survivin-mediated resistance to apoptosis. Reviewed

Shinohara T, Sawada H, Otsuki S, Yodoya N, Kato T, Ohashi H, Zhang E, Saitoh S, Shimpo H, Maruyama K, Komada Y, Mitani Y.

Vol. 308 ( 6 ) page： L523-538 2015

Potential contribution of phenotypically modulated smooth muscle cells and related inflammation in the development of experimental obstructive pulmonary vasculopathy in rats. Reviewed

Otsuki S, Sawada H, Yodoya N, Shinohara T, Kato T, Ohashi H, Zhang E, Imanaka-Yoshida K, Shimpo H, Maruyama K, Komada Y, Mitani Y.

PLOS ONE 2015

門脈体循環シャントによる肺高血圧症及び肺内シャントを合併したNoonan症候群の1例 Reviewed

永田佳敬，加藤太一，牧田智，池田麻衣子，深澤佳絵，岸本泰明，沼口敦，長井典子

日小児循環器会誌 Vol. 31 ( 4 ) page： 212-219 2015

左室心筋緻密化障害および肥大型心筋症様の所見を示したのちhistiocytoid cardiomyopathyと病理診断されたミトコンドリア病の一例 Reviewed

鬼頭　真知子、長井　典子、小沢　広明、加藤　太一、馬場　礼三

日小児循環器会誌 Vol. 30 ( 2 ) page： 205-214 2014

Central venous pressure in mechanically ventilated neonates correlates with the diameter of the inferior vena cava. Reviewed

Sato Y, Kawataki M, Hirakawa A, Toyoshima K, Kato T, Itani Y, Hayakawa M.

ACTA PAEDIATRICA Vol. 102 ( 6 ) page： e241-246 2013

Lack of CD4(+)CD25 (+)FOXP3 (+) regulatory T cells is associated with resistance to intravenous immunoglobulin therapy in patients with Kawasaki disease. Reviewed

Hirabayashi Y, Takahashi Y, Xu Y, Akane K, Villalobos IB, Okuno Y, Hasegawa S, Muramatsu H, Hama A, Kato T, Kojima S.

EUROPEAN JOURNAL OF PEDIATRICS Vol. 172 ( 6 ) page： 231-237 2013

Estrogen-like activity and dual roles in cell signaling of an Agaricus blazei Murrill mycelia-dikaryon extract. Reviewed

Dong SJ, Furutani Y, Suto Y, Furutani M, Zhu Y, Yoneyama M, Kato T, Itabe H, Nishikawa T, Tomimatsu H, Tanaka T, Kasanuki H, Masaki T, Kiyama R, Matsuoka R.

MICROBIOLOGICAL RESEARCH Vol. 167 page： 231-237 2012

Coronary arterial ectasia in a 2-year-old boy showing two symptoms of Kawasaki disease without manifesting fever. Reviewed

Kato T, Numaguchi A, Ando H, Yasui M,Kishimoto Y, Yasuda K, Fukumi D, Yasuda T.

RHEUMATOLOGY INTERNATIONAL Vol. 32 page： 1101-3 2012

　 PREV - NEXT 　

<KATO, Taichi>

Papers - KATO, Taichi